Cite

HARVARD Citation

    Alayo, Q. et al. (2021). Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases. Inflammatory bowel diseases. 27 (10), p. . [Online]. 
  
Back to record